• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TORAX MEDICAL, INC. LINX 1.5T 16 BEAD OUS; ANTI-REFLUX IMPLANT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TORAX MEDICAL, INC. LINX 1.5T 16 BEAD OUS; ANTI-REFLUX IMPLANT Back to Search Results
Catalog Number LXM16
Device Problem Appropriate Term/Code Not Available (3191)
Patient Problem Urinary Retention (2119)
Event Date 09/15/2022
Event Type  malfunction  
Manufacturer Narrative
(b)(4).Date sent: 1/9/2023.Lot number was received and dhr is pending review.When the review is completed, a supplemental medwatch will be sent with a summary of the evaluation.Additional information received: patient identifier: (b)(6), (b)(6) hospital, (b)(6), sex: male, age (at time of consent): 58 years.Start date: 15 sep 2022, alert date: 08- dec- 2022, country of event: ous, model: lxm16, device lot number: 26799, date of surgery: (b)(6) 2022 , adverse event term: painful urinary retention post surgery, site awareness date: (b)(6) 2022 , end date: (b)(6) 2022 , severity: mild, is the adverse event serious? yes, no required in-patient hospitalization or prolongation of existing hospitalization: yes, admission date: (b)(6) 2022 discharge date: (b)(6) 2022 , none: yes, relationship to primary study procedure: not related, outcome: recovered/resolved, discharge date : (b)(6) 2022 - (b)(6) 2022.If event is serious and device related, according to the protocol and instructions for use, in the opinion of the investigator, is the adverse event expected/anticipated? : blank yes.If event is serious and device related, according to the protocol and instructions for use, in the opinion of the investigator, is the adverse event expected/anticipated? : yes => no relationship to study procedure : not related, possible.Hospital stay was from sept (b)(6) 2022.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
 
Event Description
It was reported via clinical trial patient (b)(4) experience, painful urinary retention post surgery.Relationship to study device: not related.
 
Manufacturer Narrative
(b)(4).Date sent: 1/9/2023 b2: is hospitalization initial/prolonged - yes.E4: reporter also sent report to fda - no.
 
Manufacturer Narrative
(b)(4).Date sent: 1/20/2023.Investigation summary an analysis of the product could not be performed since a physical sample was not received for evaluation.As part of our company quality system process, all devices are manufactured, inspected, and distributed to approved specifications.However, if the product is received at a later date, the investigation will be updated as applicable.A manufacturing record evaluation was performed for the finished device batch number 26799 , and no related non-conformances were identified.
 
Manufacturer Narrative
(b)(4); date sent: 2/7/2023.Additional information received: required in-patient hospitalization or prolongation of existing hospitalization: yes.Admission date: (b)(6) 2022; discharge date: (b)(6) 2022.Relationship to primary study procedure: possible.If event is serious and device related, according to the protocol and instructions for use, in the opinion of the investigator, is the adverse event expected/anticipated? : no /yes.If event is serious and device related, according to the protocol and instructions for use, in the opinion of the investigator, is the adverse event expected/anticipated? : yes /n/a.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LINX 1.5T 16 BEAD OUS
Type of Device
ANTI-REFLUX IMPLANT
Manufacturer (Section D)
TORAX MEDICAL, INC.
4188 lexington avenue north
shoreview MN
Manufacturer Contact
kate karberg
4188 lexington avenue north
shoreview 
3035526892
MDR Report Key16120683
MDR Text Key308711015
Report Number3008766073-2023-00003
Device Sequence Number1
Product Code LEI
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P100049
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Study
Reporter Occupation Other
Type of Report Initial,Followup,Followup,Followup
Report Date 02/07/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/03/2024
Device Catalogue NumberLXM16
Device Lot Number26799
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 12/20/2022
Initial Date FDA Received01/09/2023
Supplement Dates Manufacturer Received12/20/2022
01/20/2023
01/24/2023
Supplement Dates FDA Received01/09/2023
01/20/2023
02/07/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/03/2020
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age58 YR
Patient SexMale
-
-